<!doctype html>
<html lang="es">
<head>
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<title>Spanish Daily – Dec 10, 2025</title>
<meta name="color-scheme" content="light dark" />
<style>
  :root { --maxw: 800px; }
  html { -webkit-text-size-adjust: 100%; }
  body { margin: 0; padding: 0; font-family: system-ui,-apple-system,Segoe UI,Roboto,Helvetica,Arial,sans-serif,Apple Color Emoji,Segoe UI Emoji; line-height: 1.6; font-size: 18px; }
  header, main, footer { max-width: var(--maxw); margin: 0 auto; padding: 16px; }
  header { padding-top: 20px; }
  h1 { font-size: 1.4rem; margin: 0 0 8px; }
  .subtle { opacity: 0.72; font-size: 0.95rem; }
  .card { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 14px; margin: 12px 0; }
  .tip-word { all: unset; display: inline; position: relative; cursor: pointer;
    text-decoration: underline dotted; text-underline-offset: 3px;
    padding: 0 .1em; border-radius: .35em; background: rgba(255,235,59,.28); }
  .tooltip { position: fixed; padding: .48rem .6rem; background: rgba(0,0,0,.88); color: #fff;
    border-radius: .55rem; font-size: .95rem; line-height: 1.3; max-width: min(90vw, 26rem);
    z-index: 9999; box-shadow: 0 6px 18px rgba(0,0,0,.18); }
  .content { white-space: pre-line; }
  .card { margin-bottom: 1.5em; line-height: 1.6; }
  strong { display: inline-block; margin-top: .35em; }
  details { border: 1px solid rgba(0,0,0,0.08); border-radius: 12px; padding: 12px; }
  details + details, details + .card { margin-top: 12px; }
  summary { cursor: pointer; font-weight: 600; }
  summary::marker { content: ""; }
  summary::after { content: " ▸"; }
  details[open] summary::after { content: " ▾"; }
  .debug { position: fixed; bottom: 8px; right: 8px; font-size: 12px; opacity: .6; }
</style>
</head>
<body>
  <header>
    <h1>Spanish Daily</h1>
    <div class="subtle">Toca una palabra subrayada para ver la traducción. Toca fuera para cerrar.</div>
  </header>

  <main>
    <!-- Spanish first -->
    <section class="card content">
STORY

<span title="Standards of Care">Los Estándares de Atención</span> de la <span title="American Diabetes Association">Asociación Americana de Diabetes</span> (ADA) <span title="now use">ahora utilizan</span> un <span title="preventive framework">marco preventivo</span> cardiometabólico-renal (CKM). También <span title="support greater use of">apoyan un mayor uso de</span> <span title="continuous glucose monitoring">monitoreo continuo de glucosa</span> (CGM). <span title="They suggest earlier use of">Sugieren el uso más temprano de</span> <span title="medications that help">medicamentos que ayudan</span> a <span title="lose weight">perder peso</span> y <span title="protect organs">protegen los órganos</span>. <span title="These changes are based on">Estos cambios se basan en</span> <span title="new data from">nuevos datos de</span> <span title="studies on outcomes">estudios sobre resultados</span> cardiovasculares, renales y de obesidad.

1) Marco CKM: <span title="Care does not focus only on">La atención no se enfoca solo en</span> la glucosa. <span title="It considers">Considera</span> el <span title="cardiovascular, kidney, and metabolic risk">riesgo cardiovascular, renal y metabólico</span> <span title="together">en conjunto</span>. <span title="It supports early and parallel care">Apoya la atención temprana y paralela</span> <span title="for all three">para los tres</span>.

2) <span title="Early stratification of CKM risk">Estratificación temprana del riesgo CKM</span>: <span title="Use eGFR, UACR, standardized risk scores">Use eGFR, UACR, puntajes estandarizados de riesgo</span> de ASCVD, <span title="blood pressure">presión arterial</span>, IMC/circunferencia de cintura <span title="at the start and at least">al inicio y al menos</span> <span title="once a year">una vez al año</span>. <span title="Use this data to">Utilice estos datos para</span> <span title="place patients into">ubicar a los pacientes en</span> <span title="CKM risk levels">niveles de riesgo CKM</span> y <span title="decide treatment intensity">decidir la intensidad del tratamiento</span>.

3) <span title="Broader use of CGM">Uso más amplio de CGM</span>: La ADA <span title="supports the use of">apoya el uso de</span> CGM <span title="for type 2 diabetes treated with">para diabetes tipo 2 tratada con</span> insulina (<span title="not just">no solo</span> basal-bolo intensivo) y <span title="some high-risk patients">algunos pacientes de alto riesgo</span> que <span title="do not use insulin">no usan insulina</span>. <span title="The goal is to">El objetivo es</span> <span title="reduce hypoglycemia">reducir la hipoglucemia</span> y <span title="improve time in range">mejorar el tiempo en rango</span>. <span title="Studies include">Los estudios incluyen</span> DIAMOND y MOBILE.

4) <span title="Metrics beyond HbA1c">Métricas más allá de HbA1c</span>: <span title="Use time in range">Use tiempo en rango</span> (70–180 mg/dL), <span title="time below range">tiempo por debajo del rango</span> y <span title="glucose variability">variabilidad glucémica</span> <span title="along with">junto con</span> HbA1c.

5) <span title="Pharmacotherapy focused on">Farmacoterapia enfocada en</span> <span title="weight loss and organ protection">pérdida de peso y protección de órganos</span>: <span title="For most adults with">Para la mayoría de los adultos con</span> diabetes tipo 2 y <span title="overweight or obesity">sobrepeso/obesidad</span>, <span title="start early">inicie temprano</span> <span title="medications that help">medicamentos que ayudan</span> a <span title="lose weight and provide CKM benefit">perder peso y brinden beneficio CKM</span>, como <span title="GLP-1 receptor agonists">agonistas del receptor GLP-1</span>, <span title="dual GIP/GLP-1 agonists">agonistas duales GIP/GLP-1</span> e <span title="SGLT2 inhibitors">inhibidores de SGLT2</span>, <span title="sometimes even when">a veces incluso cuando</span> la HbA1c inicial <span title="is not high">no es alta</span>.

<span title="For practice">Para la práctica</span>: <span title="Schedule visits according to">Programe visitas según</span> el riesgo CKM, <span title="use more CGM">use más CGM</span> y <span title="choose medications that protect">elija medicamentos que protejan</span> <span title="weight and organs">peso y órganos</span> <span title="in addition to">además de</span> <span title="controlling glucose">controlar la glucosa</span>.

---
DIALOGUE

Narrator: <span title="Today we learn about">Hoy, aprendemos sobre</span> <span title="new care for">nuevos cuidados para</span> la diabetes y la <span title="health of the heart and kidneys">salud del corazón y los riñones</span>.
Physician: Hola, <span title="I want to talk about">quiero hablar sobre</span> su diabetes y también <span title="about your heart, kidneys, and weight">sobre su corazón, riñones y peso</span>.
Patient: <span title="I try to eat well">Trato de comer bien</span> y <span title="take my pills">tomar mis pastillas</span>. <span title="Why are we checking">¿Por qué revisamos</span> mi corazón y mis riñones?
Physician: <span title="Diabetes can damage">La diabetes puede dañar</span> su corazón y sus riñones. <span title="We want to detect problems early">Queremos detectar problemas temprano</span>.
Patient: <span title="What tests are you going to do">¿Qué exámenes me van a hacer</span>?
Physician: <span title="We check eGFR for your kidneys">Revisamos el eGFR para sus riñones</span>, el UACR <span title="for protein in urine">para proteína en la orina</span> y <span title="your blood pressure">su presión arterial</span>.
Patient: <span title="Is my sugar okay">¿Mi azúcar está bien</span>?
Physician: <span title="We look at">Vemos</span> la HbA1c y también <span title="we use CGM">usamos CGM</span> <span title="to see your time in range">para ver su tiempo en rango</span> y <span title="episodes of low sugar">los episodios de azúcar baja</span>.
Patient: <span title="What is CGM">¿Qué es CGM</span>?
Physician: CGM <span title="is a small device">es un pequeño dispositivo</span>. <span title="It checks your sugar">Revisa su azúcar</span> <span title="all day">todo el día</span>. <span title="It helps to avoid">Ayuda a evitar</span> <span title="lows and highs">azúcares bajos y altos</span>.
Patient: <span title="Am I going to get a new medicine">¿Voy a recibir un medicamento nuevo</span>?
Physician: <span title="You may need">Puede que necesite</span> <span title="medications like">medicamentos como</span> GLP-1 o SGLT2. <span title="These help you lose weight">Estos le ayudan a perder peso</span> y <span title="protect your organs">protegen sus órganos</span>.
Patient: <span title="Even if my sugar is not very high">¿Aunque mi azúcar no esté muy alta</span>?
Physician: Sí, <span title="we use these medicines early">usamos estos medicamentos temprano</span> <span title="to lose weight and help">para bajar de peso y ayudar</span> <span title="your heart and kidneys">a su corazón y riñones</span>.
Narrator: <span title="The new care means">El nuevo cuidado significa</span> <span title="seeing more than just">ver más que solo</span> el azúcar. <span title="Doctors help patients">Los médicos ayudan a los pacientes</span> <span title="to stay well in many ways">a mantenerse bien de muchas maneras</span>.
    </section>

    <!-- English below -->

    <details open class="card content">
      <summary>INGLÉS</summary>
STORY

The American Diabetes Association (ADA) Standards of Care now use a preventive cardiometabolic–kidney (CKM) framework. They also support more continuous glucose monitoring (CGM). They suggest earlier use of drugs that help weight and protect organs. These changes use new data from cardiovascular, renal, and obesity outcome trials.

1) CKM framework: Care is not about glucose only. It looks at cardiovascular, kidney, and metabolic risk together. It supports early and parallel care for all three.

2) Early CKM risk stratification: Use eGFR, UACR, standardized ASCVD risk scores, blood pressure, BMI/waist at baseline and at least once each year. Use these to place patients in CKM risk tiers and choose how strong therapy should be.

3) Broader CGM use: ADA supports CGM for insulin‑treated type 2 diabetes (not only intensive basal–bolus) and some high‑risk non–insulin‑treated patients. Goal is less hypoglycemia and better time in range. Trials include DIAMOND and MOBILE.

4) Metrics beyond HbA1c: Use time in range (70–180 mg/dL), time below range, and glycemic variability with HbA1c.

5) Weight‑ and organ‑protection–focused pharmacotherapy: For most adults with type 2 diabetes and overweight/obesity, start early with drugs that give weight loss and CKM benefit, such as GLP‑1 receptor agonists, dual GIP/GLP‑1 agonists, and SGLT2 inhibitors, sometimes even when baseline HbA1c is not high.

For practice: Plan visits by CKM risk, use CGM more, and pick drugs for weight and organ protection plus glucose control.

---
DIALOGUE

Narrator: Today, we learn about new care for diabetes and heart and kidney health.
Physician: Hello, I want to talk about your diabetes and also your heart, kidneys, and weight.
Patient: I try to eat right and take my pills. Why do we check my heart and kidneys?
Physician: Diabetes can hurt your heart and kidneys. We want to catch problems early.
Patient: What tests will you do?
Physician: We check eGFR for your kidneys, UACR for protein in urine, and your blood pressure.
Patient: Is my blood sugar good?
Physician: We look at HbA1c and also use CGM to see your time in range and low sugars.
Patient: What is CGM?
Physician: CGM is a small device. It checks your sugar all day. It helps stop low and high sugars.
Patient: Will I get new medicine?
Physician: You may need medicine like GLP‑1 or SGLT2. These help you lose weight and protect your organs.
Patient: Even if my sugar is not too high?
Physician: Yes, we use these early for weight loss and to help your heart and kidneys.
Narrator: New care means looking at more than sugar. Doctors help patients stay well in many ways.
    </details>
  </main>

  <footer class="subtle">
    <div>© Dec 10, 2025 · Mezra.AI · Practica todos los días.</div>
  </footer>

  <div class="debug">EN: found</div>

  <!-- NEW: light cache-busting helper -->
  <script>
  (function() {
    // 1. Get the version tag from the URL, if present (?v=SHA...)
    var params = new URLSearchParams(window.location.search);
    var version = params.get('v');

    // 2. Read the debug indicator already inside your page
    var debug = document.querySelector('.debug');
    var debugText = debug ? debug.textContent.trim() : '';

    // 3. Heuristic: if version is missing or debug looks suspicious, force a one-time reload
    var isLikelyStale =
      !version ||
      debugText === '' ||
      debugText.indexOf('placeholder') !== -1 ||
      debugText.indexOf('not found') !== -1 ||
      debugText.length < 3;

    if (isLikelyStale) {
      if (!params.get('forceReload')) {
        params.set('forceReload', '1');
        var newUrl = window.location.pathname + '?' + params.toString();
        window.location.replace(newUrl);
      }
    }
  })();
  </script>

  <!-- Existing tooltip behavior -->
  <script>
  (function () {
    document.querySelectorAll('.content').forEach(function(container) {
      container.querySelectorAll('span[title]').forEach(function(span) {
        var text = span.textContent;
        var tip  = span.getAttribute('title');
        var btn  = document.createElement('button');
        btn.className = 'tip-word'; btn.type = 'button';
        btn.textContent = text; btn.setAttribute('data-tip', tip);
        span.replaceWith(btn);
      });
    });

    var openTip = null;
    function closeTip(){ if(openTip){ openTip.remove(); openTip = null; } }
    function showTip(target){
      closeTip();
      var tipText = target.getAttribute('data-tip') || '';
      if(!tipText) return;
      var bubble = document.createElement('div');
      bubble.className = 'tooltip';
      bubble.textContent = tipText;
      document.body.appendChild(bubble);
      var r = target.getBoundingClientRect();
      var m = 8, vw = innerWidth, vh = innerHeight;
      var rect = bubble.getBoundingClientRect();
      var tw = rect.width;
      var th = rect.height;
      var left = r.left, top = r.bottom + m;
      if (left + tw + m > vw) left = Math.max(m, vw - tw - m);
      if (left < m) left = m;
      if (top + th + m > vh) top = Math.max(m, r.top - th - m);
      bubble.style.left = left + 'px';
      bubble.style.top  = top + 'px';
      openTip = bubble;
    }

    document.addEventListener('click', function(e) {
      var word = e.target.closest('.tip-word');
      if (word){ if (openTip) closeTip(); else showTip(word); e.stopPropagation(); }
      else { closeTip(); }
    });
    document.addEventListener('touchstart', function(e) {
      if (!e.target.closest('.tip-word')) closeTip();
    }, { passive: true });
    addEventListener('scroll', closeTip, { passive: true });
    addEventListener('resize', closeTip);
    document.addEventListener('keydown', function(e) { if (e.key === 'Escape') closeTip(); });
  })();
  </script>
</body>
</html>